@article{129, keywords = {animal cell, animal experiment, animal model, Article, biomechanics, Body fluids, bone, bone defect, bone densitometry, bone density, Bone formation, bone mass, bone matrix, Bone replacement, bone transplantation, Breaking force, calvaria defect, cell adhesion, cell function, Cells, Coatings, Computerized tomography, Control groups, controlled study, Cytology, DBM, Defects, Demineralized bone matrix, ex vivo study, force, in vitro study, in vivo study, male, micro-computed tomography, Nonhealing defects, nonhuman, ossification, postoperative period, rat, rigidity, Serum Albumin, skull defect, stem cell, stem cells, tissue graft}, author = {D.B. Horváthy and G. Vácz and T. Szabó and Imola Szigyártó and I. Torő and B. Vámos and I. Hornyák and K. Renner and T. Klára and B.T. Szabó and C. Dobő-Nagy and A. Doros and Z. Lacza}, title = {Serum albumin coating of demineralized bone matrix results in stronger new bone formation}, abstract = {
Blood serum fractions are hotly debated adjuvants in bone replacement therapies. In the present experiment, we coated demineralized bone matrices (DBM) with serum albumin and investigated stem cell attachment in vitro and bone formation in a rat calvaria defect model. In the in vitro experiments, we observed that significantly more cells adhere to the serum albumin coated DBMS at every time point. In vivo bone formation with albumin coated and uncoated DBM was monitored biweekly by computed tomography until 11 weeks postoperatively while empty defects served as controls. By the seventh week, the bone defect in the albumin group was almost completely closed (remaining defect 3.0 ± 2.3%), while uncoated DBM and unfilled control groups still had significant defects (uncoated: 40.2 ± 9.1%, control: 52.4 ± 8.9%). Higher density values were also observed in the albumin coated DBM group. In addition, the serum albumin enhanced group showed significantly higher volume of newly formed bone in the microCT analysis and produced significantly higher breaking force and stiffness compared to the uncoated grafts (peak breaking force: uncoated: 15.7 ± 4 N, albumin 46.1 ± 11 N). In conclusion, this investigation shows that implanting serum albumin coated DBM significantly reduces healing period in nonhealing defects and results in mechanically stronger bone. These results also support the idea that serum albumin coating provides a convenient milieu for stem cell function, and a much improved bone grafting success can be achieved without the use of exogenous stem cells. © 2015 Wiley Periodicals, Inc.
}, year = {2016}, journal = {Journal of Biomedical Materials Research - Part B Applied Biomaterials}, volume = {104}, pages = {126-132}, month = {2016}, publisher = {John Wiley and Sons Inc.}, isbn = {15524973 (ISSN)}, url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-84952876941&partnerID=40&md5=3f3642dd5c86c82ce98043ed66033cfb}, note = {Export Date: 7 March 2016CODEN: JBMRGCorrespondence Address: Horváthy, D.B.; Institute of Human Physiology and Clinical Experimental Research, Semmelweis UniversityHungary; email: denes.horvathy@tissueengineering.huChemicals/CAS: serum albumin, 9048-46-8References: Holzmann, P., Niculescu-Morzsa, E., Zwickl, H., Halbwirth, F., Pichler, M., Matzner, M., Gottsauner-Wolf, F., Nehrer, S., Investigation of bone allografts representing different steps of the bone bank procedure using the CAM-model (2010) ALTEX, 27, pp. 97-103;Alaee, F., Hong, S.H., Dukas, A.G., Pensak, M.J., Rowe, D.W., Lieberman, J.R., Evaluation of osteogenic cell differentiation in response to bone morphogenetic protein or demineralized bone matrix in a critical sized defect model using GFP reporter mice (2014) J Orthop Res, 32, pp. 1120-1128; Hussain, A., Takahashi, K., Sonobe, J., Tabata, Y., Bessho, K., Bone regeneration of rat calvarial defect by magnesium calcium phosphate gelatin scaffolds with or without bone morphogenetic protein-2 (2014) J Maxillofac Oral Surg, 13, pp. 29-35; Liu, T., Wu, G., Wismeijer, D., Gu, Z., Liu, Y., Deproteinized bovine bone functionalized with the slow delivery of BMP-2 for the repair of critical-sized bone defects in sheep (2013) Bone, 56, pp. 110-118; Even, J., Eskander, M., Kang, J., Bone morphogenetic protein in spine surgery: Current and future uses (2012) J Am Acad Orthop Surg, 20, pp. 547-552; Fu, R., Selph, S., McDonagh, M., Peterson, K., Tiwari, A., Chou, R., Helfand, M., Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusiona systematic review and meta-analysis (2013) Ann Intern Med, 158, pp. 890-902; Malhotra, A., Pelletier, M.H., Yu, Y., Walsh, W.R., Can platelet-rich plasma (PRP) improve bone healing? A comparison between the theory and experimental outcomes (2013) Arch Orthop Trauma Surg, 133, pp. 153-165; Francis, G.L., Albumin and mammalian cell culture: Implications for biotechnology applications (2010) Cytotechnology, 62, pp. 1-16; Weszl, M., Skaliczki, G., Cselenyak, A., Kiss, L., Major, T., Schandl, K., Bognar, E., Csonge, L., Freeze-dried human serum albumin improves the adherence and proliferation of mesenchymal stem cells on mineralized human bone allografts (2012) J Orthop Res, 30, pp. 489-496; Skaliczki, G., Schandl, K., Weszl, M., Major, T., Kovacs, M., Skaliczki, J., Szendroi, M., Lacza, Z., Serum albumin enhances bone healing in a nonunion femoral defect model in rats: A computer tomography micromorphometry study (2013) Int Orthop, 37, pp. 741-745; Klara, T., Csonge, L., Janositz, G., Csernatony, Z., Lacza, Z., Albumin-coated structural lyophilized bone allografts: A clinical report of 10 cases (2014) Cell Tissue Bank, 15, pp. 89-97; Urist, M.R., Mikulski, A., Boyd, S.D., A chemosterilized antigen-extracted autodigested alloimplant for bone banks (1975) Arch Surg, 110, pp. 416-428; Holst Hansen, C.B., Nils, MTT-cell proliferation assay (1998) Cell Biology: A Laboratory Handbook, pp. 16-18. , Celis J.E. editor. San Diego: Academic Press;; Spicer, P.P., Kretlow, J.D., Young, S., Jansen, J.A., Kasper, F.K., Mikos, A.G., Evaluation of bone regeneration using the rat critical size calvarial defect (2012) Nat Protoc, 7, pp. 1918-1929; Kallai, I., Mizrahi, O., Tawackoli, W., Gazit, Z., Pelled, G., Gazit, D., Microcomputed tomography-based structural analysis of various bone tissue regeneration models (2011) Nat Protoc, 6, pp. 105-110; Kretlow, J.D., Spicer, P.P., Jansen, J.A., Vacanti, C.A., Kasper, F.K., Mikos, A.G., Uncultured marrow mononuclear cells delivered within fibrin glue hydrogels to porous scaffolds enhance bone regeneration within critical-sized rat cranial defects (2010) Tissue Eng Part A, 16, pp. 3555-3568; Evans, T.W., Review article: Albumin as a drug-biological effects of albumin unrelated to oncotic pressure (2002) Alimentary Pharmacol Ther, 16, pp. 6-11; McDowell, S.G., An, Y.H., Draughn, R.A., Friedman, R.J., Application of a fluorescent redox dye for enumeration of metabolically active bacteria on albumin-coated titanium surfaces (1995) Lett Appl Microbiol, 21, pp. 1-4; Kinnari, T.J., Peltonen, L.I., Kuusela, P., Kivilahti, J., Kononen, M., Jero, J., Bacterial adherence to titanium surface coated with human serum albumin (2005) Otol Neurotol, 26, pp. 380-384; An, Y.H., Stuart, G.W., McDowell, S.J., McDaniel, S.E., Kang, Q., Friedman, R.J., Prevention of bacterial adherence to implant surfaces with a crosslinked albumin coating in vitro (1996) J Orthop Res, 14, pp. 846-849; An, Y.H., Bradley, J., Powers, D.L., Friedman, R.J., The prevention of prosthetic infection using a cross-linked albumin coating in a rabbit model (1997) J Bone Joint Surg Br, 79, pp. 816-819; Bernards, M.T., Qin, C., Jiang, S., MC3T3-E1 cell adhesion to hydroxyapatite with adsorbed bone sialoprotein, bone osteopontin, and bovine serum albumin (2008) Colloids Surf B Biointerfaces, 64, pp. 236-247; Horvathy, D.B., Vacz, G., Cselenyak, A., Weszl, M., Kiss, L., Lacza, Z., Albumin-coated bioactive suture for cell transplantation (2013) Surg Innov, 20, pp. 249-255; Liu, X., Zhou, X., Li, S., Lai, R., Zhou, Z., Zhang, Y., Zhou, L., Effects of titania nanotubes with or without bovine serum albumin loaded on human gingival fibroblasts (2014) Int J Nanomed, 9, pp. 1185-1198; Crowley, C., Wong, J.M., Fisher, D.M., Khan, W.S., A systematic review on preclinical and clinical studies on the use of scaffolds for bone repair in skeletal defects (2013) Curr Stem Cell Res Ther, 8, pp. 243-252; Keramaris, N.C., Kaptanis, S., Moss, H.L., Loppini, M., Pneumaticos, S., Maffulli, N., Endothelial progenitor cells (EPCs) and mesenchymal stem cells (MSCs) in bone healing (2012) Curr Stem Cell Res Ther, 7, pp. 293-301; Panetta, N.J., Gupta, D.M., Longaker, M.T., Bone regeneration and repair (2010) Curr Stem Cell Res Ther, 5, pp. 122-128; Gallego, L., Junquera, L., Garcia, E., Garcia, V., Alvarez-Viejo, M., Costilla, S., Fresno, M.F., Meana, A., Repair of rat mandibular bone defects by alveolar osteoblasts in a novel plasma-derived albumin scaffold (2010) Tissue Eng Part A, 16, pp. 1179-1187}, }